_id
6914897eccc777a4e85d986e
Ticker
OXBOF
Name
Oxford BioDynamics Plc
Exchange
PINK
Address
3140 Rowan Place, Oxford, United Kingdom, OX4 2WB
Country
USA
Sector
Healthcare
Industry
Diagnostics & Research
Currency
USD
Website
https://www.oxfordbiodynamics.com
Description
Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom. The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor immunotherapy. EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation and monitoring of 3D genomic biomarker. Its products include EpiSwitch Prostate Screening Test (PSE), a prostate cancer screening test; EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a blood test for predicting therapeutic response to checkpoint inhibitor immunotherapy; EpiSwitch Orion, a cloud platform, running on google cloud architecture; and EpiSwitch Explorer Array Kit platform, enabling advanced analysis of 3D regulatory control points. The company was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.
Last Close
0.0014
Volume
-
Current Price
0.0035
Change
0
Last Updated
2026-01-06T08:47:32.675Z
Image
data:image/webp;base64,UklGRjQBAABXRUJQVlA4ICgBAABQBwCdASpAAEAAPtFUqEwoJKQiLh25yQAaCWkA1bwIHYEGBKge4qOhoQ/rOz2+Cv+XhLzWglq8FM285Nyp0o84fPwAAP72puJQ5ckU+5Hk6Fsg9cQuxgPpUFjBUDhzKv1GWY4a0HDNaDCcQK0SlF8UyaHVTnOcbZX5MLxR7m/Ts56R3CiaYNQ90nVooU8NbWEqOpuFTMz/3ZZGC5C45H9GeXkBqd1D5Kh/QdDfaqW7GxSWapsr62POlLiJOH4LINdxvmWqRhL/WccVhU3I5M62WmDz5NOnM83zFOwl1NsQlARMZNVjPV9fzm9EtnusU56w7deCvvQ7z8I9cXMxG5+JxYaGGWJsJQMq5UlMepPDN1gNhQrXkF0qv/gy1Tyt2DeHL60tAAAAAA==
Ipo Date
-
Market Cap
6007275
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
508000
Cost Of Revenue
4812236
Gross Profit
-4129382
Operating Expenses
2418215
Operating Income
-5198000
Interest Expense
275561
Pretax Income
-5530000
Net Income
-7261368
Eps
-0.0064896009196723945
Dividends Per Share
-
Shares Outstanding
4290910967
Income Tax Expense
-172057
EBITDA
-4184000
Operating Margin
-1023.228346456693
Total Other Income Expense Net
-332000
Cash
1871126
Short Term Investments
-
Receivables
932874
Inventories
262119
Total Current Assets
3066120
Property Plant Equipment
4699000
Total Assets
10869201
Payables
1771655
Short Term Debt
3019329
Long Term Debt
-
Total Liabilities
9369074
Equity
1500127
Bs_currency_symbol
GBP
Depreciation
763505
Change In Working Capital
955726
Cash From Operations
-3712680
Capital Expenditures
22851
Cash From Investing
-90061
Cash From Financing
-44358
Net Change In Cash
-3631955
Cf_currency_symbol
-
PE
-
PB
2.6106008377957335
ROE
-484.0502170816205
ROA
-66.80682416306406
FCF
-3735531
Fcf Percent
-7.353407480314961
Piotroski FScore
1
Health Score
17
Deep Value Investing Score
3.5
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
2.8
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
2
Net Net Investing Score
1.5
Quality Investing Score
1
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
508000
Quarters > 0 > income Statement > cost Of Revenue
4812236
Quarters > 0 > income Statement > gross Profit
-4129382
Quarters > 0 > income Statement > operating Expenses
2418215
Quarters > 0 > income Statement > operating Income
-5198000
Quarters > 0 > income Statement > interest Expense
275561
Quarters > 0 > income Statement > pretax Income
-5530000
Quarters > 0 > income Statement > net Income
-7261368
Quarters > 0 > income Statement > eps
-0.0064896009196723945
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1118923658
Quarters > 0 > income Statement > income Tax Expense
-172057
Quarters > 0 > income Statement > EBITDA
-4184000
Quarters > 0 > income Statement > operating Margin
-1023.228346456693
Quarters > 0 > income Statement > total Other Income Expense Net
-332000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
1871126
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
932874
Quarters > 0 > balance Sheet > inventories
262119
Quarters > 0 > balance Sheet > total Current Assets
3066120
Quarters > 0 > balance Sheet > property Plant Equipment
4699000
Quarters > 0 > balance Sheet > total Assets
10869201
Quarters > 0 > balance Sheet > payables
1771655
Quarters > 0 > balance Sheet > short Term Debt
3019329
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
9369074
Quarters > 0 > balance Sheet > equity
1500127
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-7261368
Quarters > 0 > cash Flow > depreciation
763505
Quarters > 0 > cash Flow > change In Working Capital
955726
Quarters > 0 > cash Flow > cash From Operations
-3712680
Quarters > 0 > cash Flow > capital Expenditures
22851
Quarters > 0 > cash Flow > cash From Investing
-90061
Quarters > 0 > cash Flow > cash From Financing
-44358
Quarters > 0 > cash Flow > net Change In Cash
-3631955
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.0064896009196723945
Quarters > 0 > ratios > PB
2.6106008377957335
Quarters > 0 > ratios > ROE
-484.0502170816205
Quarters > 0 > ratios > ROA
-66.80682416306406
Quarters > 0 > ratios > FCF
-3735531
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-7.353407480314961
Quarters > 0 > health Score
17
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
587000
Quarters > 1 > income Statement > cost Of Revenue
281000
Quarters > 1 > income Statement > gross Profit
306000
Quarters > 1 > income Statement > operating Expenses
6182000
Quarters > 1 > income Statement > operating Income
-5876000
Quarters > 1 > income Statement > interest Expense
146439
Quarters > 1 > income Statement > pretax Income
-5892000
Quarters > 1 > income Statement > net Income
-5751000
Quarters > 1 > income Statement > eps
-0.006759741612796819
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
850772164
Quarters > 1 > income Statement > income Tax Expense
141000
Quarters > 1 > income Statement > EBITDA
-5617000
Quarters > 1 > income Statement > operating Margin
-1001.0221465076661
Quarters > 1 > income Statement > total Other Income Expense Net
-16000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
4261000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1442000
Quarters > 1 > balance Sheet > inventories
289000
Quarters > 1 > balance Sheet > total Current Assets
6654000
Quarters > 1 > balance Sheet > property Plant Equipment
5208000
Quarters > 1 > balance Sheet > total Assets
13302000
Quarters > 1 > balance Sheet > payables
1717000
Quarters > 1 > balance Sheet > short Term Debt
1952358
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
7374000
Quarters > 1 > balance Sheet > equity
5928000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
-5751000
Quarters > 1 > cash Flow > depreciation
630000
Quarters > 1 > cash Flow > change In Working Capital
241510
Quarters > 1 > cash Flow > cash From Operations
-6389050
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
1062904
Quarters > 1 > cash Flow > cash From Financing
8460616
Quarters > 1 > cash Flow > net Change In Cash
3060017
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.006759741612796819
Quarters > 1 > ratios > PB
0.5023115003373819
Quarters > 1 > ratios > ROE
-97.01417004048582
Quarters > 1 > ratios > ROA
-43.234100135318
Quarters > 1 > ratios > FCF
-6389050
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-10.884241908006814
Quarters > 1 > health Score
23
Quarters > 2 > quarter
2024-09-30
Quarters > 2 > income Statement > revenue
309000
Quarters > 2 > income Statement > cost Of Revenue
154000
Quarters > 2 > income Statement > gross Profit
155000
Quarters > 2 > income Statement > operating Expenses
7056000
Quarters > 2 > income Statement > operating Income
-6901000
Quarters > 2 > income Statement > interest Expense
-9000
Quarters > 2 > income Statement > pretax Income
-7081000
Quarters > 2 > income Statement > net Income
-6842000
Quarters > 2 > income Statement > eps
-0.026754896667149718
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
255728889
Quarters > 2 > income Statement > income Tax Expense
-239000
Quarters > 2 > income Statement > EBITDA
-4599000
Quarters > 2 > income Statement > operating Margin
-2233.333333333333
Quarters > 2 > income Statement > total Other Income Expense Net
-180000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
1827000
Quarters > 2 > balance Sheet > short Term Investments
1000000
Quarters > 2 > balance Sheet > receivables
1385000
Quarters > 2 > balance Sheet > inventories
321000
Quarters > 2 > balance Sheet > total Current Assets
5046000
Quarters > 2 > balance Sheet > property Plant Equipment
5711000
Quarters > 2 > balance Sheet > total Assets
12108000
Quarters > 2 > balance Sheet > payables
953000
Quarters > 2 > balance Sheet > short Term Debt
2444711
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
7750000
Quarters > 2 > balance Sheet > equity
4358000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-7231000
Quarters > 2 > cash Flow > depreciation
738000
Quarters > 2 > cash Flow > change In Working Capital
-667000
Quarters > 2 > cash Flow > cash From Operations
-6702000
Quarters > 2 > cash Flow > capital Expenditures
529000
Quarters > 2 > cash Flow > cash From Investing
-1226000
Quarters > 2 > cash Flow > cash From Financing
8580000
Quarters > 2 > cash Flow > net Change In Cash
640000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.026754896667149718
Quarters > 2 > ratios > PB
0.2053811637218908
Quarters > 2 > ratios > ROE
-156.99862322166132
Quarters > 2 > ratios > ROA
-56.50809382226627
Quarters > 2 > ratios > FCF
-7231000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-23.401294498381876
Quarters > 2 > health Score
24
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
327000
Quarters > 3 > income Statement > cost Of Revenue
193000
Quarters > 3 > income Statement > gross Profit
134000
Quarters > 3 > income Statement > operating Expenses
6127000
Quarters > 3 > income Statement > operating Income
-5993000
Quarters > 3 > income Statement > interest Expense
234000
Quarters > 3 > income Statement > pretax Income
-4875000
Quarters > 3 > income Statement > net Income
-4725000
Quarters > 3 > income Statement > eps
-0.023356007114363343
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
202303415
Quarters > 3 > income Statement > income Tax Expense
-150000
Quarters > 3 > income Statement > EBITDA
-5666000
Quarters > 3 > income Statement > operating Margin
-1832.7217125382263
Quarters > 3 > income Statement > total Other Income Expense Net
1118000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
1187000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1156000
Quarters > 3 > balance Sheet > inventories
229000
Quarters > 3 > balance Sheet > total Current Assets
2572000
Quarters > 3 > balance Sheet > property Plant Equipment
6385000
Quarters > 3 > balance Sheet > total Assets
11066000
Quarters > 3 > balance Sheet > payables
2665000
Quarters > 3 > balance Sheet > short Term Debt
1900332
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
9444000
Quarters > 3 > balance Sheet > equity
1622000
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
-4725000
Quarters > 3 > cash Flow > depreciation
728000
Quarters > 3 > cash Flow > change In Working Capital
26000
Quarters > 3 > cash Flow > cash From Operations
-3470000
Quarters > 3 > cash Flow > capital Expenditures
66000
Quarters > 3 > cash Flow > cash From Investing
-259000
Quarters > 3 > cash Flow > cash From Financing
-326000
Quarters > 3 > cash Flow > net Change In Cash
-4063000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.023356007114363343
Quarters > 3 > ratios > PB
0.43653634556103577
Quarters > 3 > ratios > ROE
-291.3070283600493
Quarters > 3 > ratios > ROA
-42.69835532260979
Quarters > 3 > ratios > FCF
-3536000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-10.813455657492355
Quarters > 3 > health Score
16
Annuals > 0 > quarter
2025-09-30
Annuals > 0 > income Statement > revenue
1095000
Annuals > 0 > income Statement > cost Of Revenue
9737384
Annuals > 0 > income Statement > gross Profit
-8265485
Annuals > 0 > income Statement > operating Expenses
11596000
Annuals > 0 > income Statement > operating Income
-11074000
Annuals > 0 > income Statement > interest Expense
422000
Annuals > 0 > income Statement > pretax Income
-11422000
Annuals > 0 > income Statement > net Income
-14991862
Annuals > 0 > income Statement > eps
-0.01080825503822449
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1387075152
Annuals > 0 > income Statement > income Tax Expense
-269000
Annuals > 0 > income Statement > EBITDA
-9801000
Annuals > 0 > income Statement > operating Margin
-1011.3242009132421
Annuals > 0 > income Statement > total Other Income Expense Net
-348000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
1871126
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
932874
Annuals > 0 > balance Sheet > inventories
195000
Annuals > 0 > balance Sheet > total Current Assets
3066120
Annuals > 0 > balance Sheet > property Plant Equipment
4699000
Annuals > 0 > balance Sheet > total Assets
10869201
Annuals > 0 > balance Sheet > payables
1771655
Annuals > 0 > balance Sheet > short Term Debt
1288000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
9369074
Annuals > 0 > balance Sheet > equity
1500127
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-11422000
Annuals > 0 > cash Flow > depreciation
1199000
Annuals > 0 > cash Flow > change In Working Capital
1207091
Annuals > 0 > cash Flow > cash From Operations
-10362437
Annuals > 0 > cash Flow > capital Expenditures
244000
Annuals > 0 > cash Flow > cash From Investing
1016215
Annuals > 0 > cash Flow > cash From Financing
8761495
Annuals > 0 > cash Flow > net Change In Cash
-571938
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.01080825503822449
Annuals > 0 > ratios > PB
1.294493874718607
Annuals > 0 > ratios > ROE
-999.3728530984378
Annuals > 0 > ratios > ROA
-137.92975215013504
Annuals > 0 > ratios > FCF
-10606437
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-9.686243835616438
Annuals > 0 > health Score
16
Annuals > 1 > quarter
2024-09-30
Annuals > 1 > income Statement > revenue
636000
Annuals > 1 > income Statement > cost Of Revenue
347000
Annuals > 1 > income Statement > gross Profit
289000
Annuals > 1 > income Statement > operating Expenses
13183000
Annuals > 1 > income Statement > operating Income
-12894000
Annuals > 1 > income Statement > interest Expense
225000
Annuals > 1 > income Statement > pretax Income
-11956000
Annuals > 1 > income Statement > net Income
-11567000
Annuals > 1 > income Statement > eps
-0.045231495140152116
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
255728889
Annuals > 1 > income Statement > income Tax Expense
-389000
Annuals > 1 > income Statement > EBITDA
-10265000
Annuals > 1 > income Statement > operating Margin
-2027.3584905660377
Annuals > 1 > income Statement > total Other Income Expense Net
938000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
1827000
Annuals > 1 > balance Sheet > short Term Investments
1000000
Annuals > 1 > balance Sheet > receivables
1385000
Annuals > 1 > balance Sheet > inventories
321000
Annuals > 1 > balance Sheet > total Current Assets
5046000
Annuals > 1 > balance Sheet > property Plant Equipment
5711000
Annuals > 1 > balance Sheet > total Assets
12108000
Annuals > 1 > balance Sheet > payables
953000
Annuals > 1 > balance Sheet > short Term Debt
1046000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
7750000
Annuals > 1 > balance Sheet > equity
4358000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-11956000
Annuals > 1 > cash Flow > depreciation
1466000
Annuals > 1 > cash Flow > change In Working Capital
-857145
Annuals > 1 > cash Flow > cash From Operations
-10172000
Annuals > 1 > cash Flow > capital Expenditures
595000
Annuals > 1 > cash Flow > cash From Investing
-1485000
Annuals > 1 > cash Flow > cash From Financing
8254000
Annuals > 1 > cash Flow > net Change In Cash
-3423000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.045231495140152116
Annuals > 1 > ratios > PB
0.08215246548875632
Annuals > 1 > ratios > ROE
-265.41991739329967
Annuals > 1 > ratios > ROA
-95.53187974892633
Annuals > 1 > ratios > FCF
-10767000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-16.92924528301887
Annuals > 1 > health Score
23
Annuals > 2 > quarter
2023-09-30
Annuals > 2 > income Statement > revenue
510000
Annuals > 2 > income Statement > cost Of Revenue
244000
Annuals > 2 > income Statement > gross Profit
266000
Annuals > 2 > income Statement > operating Expenses
10434000
Annuals > 2 > income Statement > operating Income
-10168000
Annuals > 2 > income Statement > interest Expense
213000
Annuals > 2 > income Statement > pretax Income
-11411000
Annuals > 2 > income Statement > net Income
-10826000
Annuals > 2 > income Statement > eps
-0.0734057841506782
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
147481566
Annuals > 2 > income Statement > income Tax Expense
-585000
Annuals > 2 > income Statement > EBITDA
-9841000
Annuals > 2 > income Statement > operating Margin
-1993.7254901960785
Annuals > 2 > income Statement > total Other Income Expense Net
-1243000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
5250000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
76000
Annuals > 2 > balance Sheet > inventories
274000
Annuals > 2 > balance Sheet > total Current Assets
7167000
Annuals > 2 > balance Sheet > property Plant Equipment
6997000
Annuals > 2 > balance Sheet > total Assets
16127000
Annuals > 2 > balance Sheet > payables
485000
Annuals > 2 > balance Sheet > short Term Debt
818000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
10072000
Annuals > 2 > balance Sheet > equity
6055000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-11411000
Annuals > 2 > cash Flow > depreciation
1357000
Annuals > 2 > cash Flow > change In Working Capital
-671000
Annuals > 2 > cash Flow > cash From Operations
-8294000
Annuals > 2 > cash Flow > capital Expenditures
716000
Annuals > 2 > cash Flow > cash From Investing
-620000
Annuals > 2 > cash Flow > cash From Financing
13207000
Annuals > 2 > cash Flow > net Change In Cash
4276000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.0734057841506782
Annuals > 2 > ratios > PB
0.034099784046242775
Annuals > 2 > ratios > ROE
-178.7943848059455
Annuals > 2 > ratios > ROA
-67.12965833695046
Annuals > 2 > ratios > FCF
-9010000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-17.666666666666668
Annuals > 2 > health Score
24
Annuals > 3 > quarter
2022-09-30
Annuals > 3 > income Statement > revenue
154000
Annuals > 3 > income Statement > cost Of Revenue
38000
Annuals > 3 > income Statement > gross Profit
116000
Annuals > 3 > income Statement > operating Expenses
8717000
Annuals > 3 > income Statement > operating Income
-8601000
Annuals > 3 > income Statement > interest Expense
195000
Annuals > 3 > income Statement > pretax Income
-7567000
Annuals > 3 > income Statement > net Income
-6710000
Annuals > 3 > income Statement > eps
-0.06730038217690498
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
99702257
Annuals > 3 > income Statement > income Tax Expense
-857000
Annuals > 3 > income Statement > EBITDA
-6766000
Annuals > 3 > income Statement > operating Margin
-5585.064935064935
Annuals > 3 > income Statement > total Other Income Expense Net
1034000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
974000
Annuals > 3 > balance Sheet > short Term Investments
25000
Annuals > 3 > balance Sheet > receivables
12000
Annuals > 3 > balance Sheet > inventories
337000
Annuals > 3 > balance Sheet > total Current Assets
2765000
Annuals > 3 > balance Sheet > property Plant Equipment
6978000
Annuals > 3 > balance Sheet > total Assets
11344000
Annuals > 3 > balance Sheet > payables
857000
Annuals > 3 > balance Sheet > short Term Debt
1557376
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
8756000
Annuals > 3 > balance Sheet > equity
2588000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-7567000
Annuals > 3 > cash Flow > depreciation
1213000
Annuals > 3 > cash Flow > change In Working Capital
999000
Annuals > 3 > cash Flow > cash From Operations
-5177000
Annuals > 3 > cash Flow > capital Expenditures
901000
Annuals > 3 > cash Flow > cash From Investing
1251000
Annuals > 3 > cash Flow > cash From Financing
2562000
Annuals > 3 > cash Flow > net Change In Cash
-1201000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-0.06730038217690498
Annuals > 3 > ratios > PB
0.05393476035548686
Annuals > 3 > ratios > ROE
-259.27357032457496
Annuals > 3 > ratios > ROA
-59.15021156558533
Annuals > 3 > ratios > FCF
-6078000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-39.467532467532465
Annuals > 3 > health Score
15
Valuation > metrics > PE
-0.0064896009196723945
Valuation > metrics > PB
2.6106008377957335
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-484.0502170816205
Profitability > metrics > ROA
-236.82595593127468
Profitability > metrics > Net Margin
-14.294031496062992
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
6.2455205459271115
Risk > metrics > Interest Coverage
-18.863336974390425
Risk > final Score
-69
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.6399770903012826
Liquidity > metrics > Quick Ratio
0.5852662000123565
Liquidity > final Score
39
Liquidity > verdict
Weak
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-131
Prev Risks > 1
-3037
Prev Risks > 2
-96
Prev Liquidities > 0
95
Prev Liquidities > 1
87
Prev Liquidities > 2
36
Updated At
2026-01-20T22:21:51.659Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2020-12-31
Earnings History > 1 > report Date
2021-01-27
Earnings History > 1 > date
2020-12-31
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
GBP
Earnings History > 1 > eps Actual
-0.0229
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.0229
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2020-09-30
Earnings History > 2 > report Date
2020-12-31
Earnings History > 2 > date
2020-09-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
GBP
Earnings History > 2 > eps Actual
-0.0227
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.0227
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2020-06-30
Earnings History > 3 > report Date
2020-09-30
Earnings History > 3 > date
2020-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
GBP
Earnings History > 3 > eps Actual
-0.0159
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.0159
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2020-03-31
Earnings History > 4 > report Date
2020-06-30
Earnings History > 4 > date
2020-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
GBP
Earnings History > 4 > eps Actual
-0.0153
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.0153
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2019-12-31
Earnings History > 5 > report Date
2020-01-22
Earnings History > 5 > date
2019-12-31
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
GBP
Earnings History > 5 > eps Actual
-0.0136
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.0136
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2019-09-30
Earnings History > 6 > report Date
2019-12-31
Earnings History > 6 > date
2019-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
GBP
Earnings History > 6 > eps Actual
-0.0145
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.0145
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2019-06-30
Earnings History > 7 > report Date
2019-09-30
Earnings History > 7 > date
2019-06-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
GBP
Earnings History > 7 > eps Actual
-0.0101
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.0101
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-03-31
Earnings History > 8 > report Date
2019-05-27
Earnings History > 8 > date
2019-03-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
GBP
Earnings History > 8 > eps Actual
-0.0104
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.0104
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2018-12-31
Earnings History > 9 > report Date
2019-03-31
Earnings History > 9 > date
2018-12-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
GBP
Earnings History > 9 > eps Actual
-0.009
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.009
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2018-09-30
Earnings History > 10 > report Date
2018-12-11
Earnings History > 10 > date
2018-09-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
GBP
Earnings History > 10 > eps Actual
-0.0088
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.0088
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-06-30
Earnings History > 11 > report Date
2018-09-30
Earnings History > 11 > date
2018-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
GBP
Earnings History > 11 > eps Actual
-0.006
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.006
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-03-31
Earnings History > 12 > report Date
2018-05-21
Earnings History > 12 > date
2018-03-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
GBP
Earnings History > 12 > eps Actual
-0.0061
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.0061
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2017-12-31
Earnings History > 13 > report Date
2018-01-29
Earnings History > 13 > date
2017-12-31
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
GBP
Earnings History > 13 > eps Actual
-0.0091
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.0091
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-09-30
Earnings History > 14 > report Date
2017-12-31
Earnings History > 14 > date
2017-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
GBP
Earnings History > 14 > eps Actual
-0.0088
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.0088
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2017-06-30
Earnings History > 15 > report Date
2017-09-30
Earnings History > 15 > date
2017-06-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
GBP
Earnings History > 15 > eps Actual
-0.0091
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.0091
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2017-03-31
Earnings History > 16 > report Date
2017-06-12
Earnings History > 16 > date
2017-03-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
GBP
Earnings History > 16 > eps Actual
-0.0088
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.0088
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2016-12-31
Earnings History > 17 > report Date
2017-01-30
Earnings History > 17 > date
2016-12-31
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
GBP
Earnings History > 17 > eps Actual
-0.0196
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.0196
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2016-09-30
Earnings History > 18 > report Date
2016-12-14
Earnings History > 18 > date
2016-09-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
GBP
Earnings History > 18 > eps Actual
-0.0192
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.0192
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2016-06-30
Earnings History > 19 > report Date
2016-09-30
Earnings History > 19 > date
2016-06-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
GBP
Earnings History > 19 > eps Actual
-0.0075
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.0075
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2016-03-31
Earnings History > 20 > report Date
2016-06-30
Earnings History > 20 > date
2016-03-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
GBP
Earnings History > 20 > eps Actual
-0.0077
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.0077
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2015-12-31
Earnings History > 21 > report Date
2016-03-31
Earnings History > 21 > date
2015-12-31
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
GBP
Earnings History > 21 > eps Actual
-0.0069
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.0069
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2015-09-30
Earnings History > 22 > report Date
2015-12-31
Earnings History > 22 > date
2015-09-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
GBP
Earnings History > 22 > eps Actual
-0.0071
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.0071
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2015-06-30
Earnings History > 23 > report Date
2015-09-30
Earnings History > 23 > date
2015-06-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
GBP
Earnings History > 23 > eps Actual
-0.0063
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.0063
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2015-03-31
Earnings History > 24 > report Date
2015-06-30
Earnings History > 24 > date
2015-03-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
GBP
Earnings History > 24 > eps Actual
-0.0066
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-0.0066
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2014-12-31
Earnings History > 25 > report Date
2015-03-31
Earnings History > 25 > date
2014-12-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
GBP
Earnings History > 25 > eps Actual
-0.0032
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.0032
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2014-09-30
Earnings History > 26 > report Date
2014-12-31
Earnings History > 26 > date
2014-09-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
GBP
Earnings History > 26 > eps Actual
-0.0034
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-0.0034
Earnings History > 26 > surprise Percent
-
Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom. The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor immunotherapy. EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation and monitoring of 3D genomic biomarker. Its products include EpiSwitch Prostate Screening Test (PSE), a prostate cancer screening test; EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a blood test for predicting therapeutic response to checkpoint inhibitor immunotherapy; EpiSwitch Orion, a cloud platform, running on google cloud architecture; and EpiSwitch Explorer Array Kit platform, enabling advanced analysis of 3D regulatory control points. The company was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AOxford BioDynamics shares soar 33% after unveiling breakthrough blood test for Chronic Fatigue Syndrome Proactive Investors
Read more →Market movers: Joby Aviation, AST SpaceMobile, Jefferies Financial Group… Proactive financial news
Read more →Showing 2 of 3
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Oxford BioDynamics Plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2020-12-31
EPS Actual
-0.0229
EPS Estimate
0
EPS Difference
-0.0229
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.